The emotional design principle avers that highly saturated warm colors in multimedia learning presentations can elevate affective-motivational, cognitive, and learning outcomes. While warm and achromatic grayscale color tones have been explored extensively, relatively less research examines the effects of cold colors in multimedia learning. This study explores how color tones (warm, cold, and achromatic grayscale) and learners’ gender influence positive emotions, intrinsic motivation, cognitive load, and transfer performance. An online experiment was conducted where learners pursuing IT courses in an Asian university ( ) engaged with either one of the multimedia learning lessons on distributed denial-of-service attack imbued with (1) a warm color tone, (2) a cold color tone, and (3) an achromatic grayscale color tone. Findings show that the cold color tone was associated with fewer enhanced positive emotion types than the other color tones. Compared to the achromatic grayscale color tone ( , ), significantly higher extraneous cognitive load ratings were observed with the warm color tone ( , ) and the cold color tone ( , ). Following reports by some learners, this could be attributed to the overly vivid and saturated chromatic colors impairing the learners’ visual and cognitive processes, causing them to rate the multimedia learning experience with warm and cold color tones as more difficult than with the achromatic grayscale color tone. Male learners in the warm color tone condition ( , ) performed marginally better on the transfer posttest than male learners in the cold color tone condition ( , ) and male learners in the achromatic grayscale color tone condition ( , ). In contrast, female learners in the warm color tone condition ( ,
This study investigates the factors influencing the intention to use AI-powered health diagnostic chatbots. A research model was proposed based on the Technology Acceptance Model, subjective norms, perceived trust, perceived risk, and self-efficacy. Using Partial Least Squares Structural Equation Modeling, the study assessed the model with 274 valid responses. The results revealed that perceived usefulness, subjective norms, perceived trust, and self-efficacy significantly influence the intention to use AI-powered health diagnostic chatbots. However, perceived ease of use and perceived risk did not impact the intention to use such chatbots. The study also discusses how these findings can assist developers in promoting the long-term adoption of AI-powered health diagnostic chatbots among potential users.
Pancreatic Cancer (PC) remains one of the most aggressive and lethal malignancies with an extremely low survival rate. Existing conventional therapies such as surgery, chemotherapy, radiotherapy, and immunotherapy have demonstrated limited effectiveness in significantly improving overall survival outcomes, largely due to the unique and hostile Tumour Microenvironment (TME) of PC. The TME is characterised by a desmoplastic stroma, an immunosuppressive, hypovascular, and hypoxic microenvironment, which collectively contribute to therapeutic failure. These features not only limit effective drug delivery but also promote tumour progression and treatment resistance. In recent years, the emergence of molecular targeted therapies has enabled the targeting of aberrantly activated kinases or other highly expressed targets in PC, such as KRAS, CDKN2A, TP53, SMAD4, epigenetic regulators, and signalling pathways. However, the clinical efficacy of many targeted agents remains limited, highlighting the complexity of tumour heterogeneity and adaptive resistance mechanisms. These limitations underscore the need to develop more effective therapeutic strategies for PC. Advances in precision oncology, immunotherapy, and patient derived models offer promising opportunities to improve the understanding of tumour biology, elucidate mechanisms underlying therapeutic response and resistance, and identify novel treatment strategies tailored to individual patients. Herein, this review aims to provide an updated overview of the current state of molecular therapies and the underlying molecular mechanisms and oncogenic pathways that contribute to PC initiation, development, progression and metastasis.